1 / 21

Schizophrenia: brain chemicals

Schizophrenia: brain chemicals. How might neurotransmitters be implicated in mental illness?. Today’s session. Neurones. Neuronal cell bodies. Axons. Source: science photo library. Synapses occur at the junctions. Synapses. Neurones transmit signals electrically along their axons

grimms
Download Presentation

Schizophrenia: brain chemicals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Schizophrenia: brain chemicals • How might neurotransmitters be implicated in mental illness?

  2. Today’s session

  3. Neurones Neuronal cell bodies Axons Source: science photo library Synapses occur at the junctions

  4. Synapses • Neurones transmit signals electrically along their axons • The synapses (junctions between neurones) transmit signals chemically

  5. Synapse Vesicles filled with neurotransmitter Synaptic cleft Source: neuroscience.wustl.edu Location of receptors (post-synaptic density)

  6. Vesicles release neurotransmitter into synaptic cleft

  7. Neurotransmitter binds to receptors & activates them

  8. Enzymes are released to break down the neurotransmitter

  9. Excess neurotransmitter is taken up by the pre-synaptic neurone

  10. Vesicles are replenished with new & reused neurotransmitter

  11. The dopamine hypothesis • Schizophrenia is caused by excessive activity at synapses that use dopamine as their primary neurotransmitter • This causes abnormal functioning of DA-dependent brain systems, resulting in schizophrenic symptoms

  12. Biology and Schizophrenia • Consistent evidence for abnormal brain functioning in S patients but no single factor identified. • Two syndromes? • Cause & effect issues everywhere • Confounding effects of drug treatment

  13. What could be done to make dopamine synapses less active?

  14. Antipsychotic medication • Neuroleptics (e.g. chlorpromazine) bind to DA receptors without activating them

  15. Effectiveness • Older (typical) drugs (e.g. chlorpromazine) • Short term beneficial effect in 75% of patients (Davis et al, 1989) • Long term beneficial effect in 55-60% (Davis et al, 1993) • Most effective against positive symptoms • High risk of side effects

  16. Side effects • Extrapyramidal side effects (EPS) • Parkinson’s-type symptoms • Postural & motor abnormalities • Other side effects • Sedation • Weight gain • Seizures

  17. What implications arise from the side effects of antipsychotic drugs?

  18. Effectiveness • Newer (atypical) drugs (e.g. clozapine) • As effective as typical drugs on positive symptoms; better for negative symptoms (Bilder et al, 2002) • More effective with treatment-resistant patients (DeNayer et al, 2003) • Less risk of EPS, but other side effects may occur (e.g. blood disorders)

  19. Typical vs. atypical tightly bound; slow release from receptor loosely bound; fast release from receptor Drug DA receptor

More Related